N-Substituted Phenylhydrazones Kill the Ring Stage of Plasmodium falciparum
Authors:
- Cedric Dzidzor Kodjo AmengorCACedric Dzidzor Kodjo Amengor
- Prince Danan BiniyamPBPrince Danan Biniyam
- Abena Amponsaa BrobbeyABAbena Amponsaa Brobbey
- Francis Klenam KekessieFKFrancis Klenam Kekessie
- Felix Kwame ZoikuFZFelix Kwame Zoiku
- Sherif HamiduSHSherif Hamidu
- Patrick GyanPGPatrick Gyan
- Billy Mawunyo AbudeyBABilly Mawunyo Abudey
Open Access
- 13 February 2024
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2024, 1-13
Abstract
Antimalarial resistance has hampered the effective treatment of malaria, a parasitic disease caused by Plasmodium species. As part of our campaign on phenotypic screening of phenylhydrazones, a library of six phenylhydrazones was reconstructed and evaluated for their in vitro antimalarial and in silico receptor binding and pharmacokinetic properties. The structures of the phenylhydrazone hybrids were largely confirmed using nuclear magnetic resonance techniques. We identified two compounds which exhibited significant antimalarial potential against the ring stage (trophozoite) of 3D7 chloroquine-sensitive (CS) strain and DD2 chloroquine-resistant (CR) strains of Plasmodium falciparum with monosubstituted analogs bearing meta or para electron-donating groups showing significant activity in the single-digit micromolar range. Structure activity relationship is presented showing that electron-donating groups on the substituent hydrophobic pharmacophore are required for antimalarial activity. Compounds PHN6 and PHN3 were found to be the most potent with pIC50s (calculated form in vitro IC50s) of 5.37 and 5.18 against 3D7 CS and DD2 CR strains, respectively. Our selected ligands (PHN3 and PHN6) performed better when compared to chloroquine regarding binding affinity and molecular stability with the regulatory proteins of Plasmodium falciparum, hence predicted to be largely responsible for their in vitro activity. Pharmacokinetic prediction demonstrated that the phenylhydrazones may not cross the blood-brain barrier and are not P-glycoprotein (P-gp) substrates, a good absorption of 62 to 69, and classified as a category IV compound based on toxicity grading.Keywords
This publication has 27 references indexed in Scilit:
- Synthesis, Biological Activity, and Mechanism of Action of 2‐Pyrazyl and Pyridylhydrazone Derivatives, New Classes of Antileishmanial AgentsChemMedChem, 2018
- In silicoADME-Tox modeling: progress and prospectsExpert Opinion on Drug Metabolism & Toxicology, 2017
- Colorimetric Recognition of Aldehydes and KetonesAngewandte Chemie, 2017
- Endoperoxide Drug Cross-Resistance Patterns for Plasmodium falciparum Exhibiting an Artemisinin Delayed-Clearance PhenotypeAntimicrobial Agents and Chemotherapy, 2016
- Artemisinin anti-malarial drugs in ChinaActa Pharmaceutica Sinica B, 2016
- Malaria resurgence: a systematic review and assessment of its causesMalaria Journal, 2012
- Plasmodium falciparum: Assessment of Selectivity of Action of Chloroquine, Alchornea cordifolia, Ficus polita, and Other Drugs by a Tetrazolium-Based Colorimetric AssayMalaria Research and Treatment, 2011
- Falcipains, Plasmodium falciparum Cysteine Proteases as Key Drug Targets Against MalariaCurrent Medicinal Chemistry, 2011
- Inhibitor Binding to the Plasmepsin IV Aspartic Protease from Plasmodium falciparumBiochemistry, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004